基于多种氨基酸的药物输送纳米颗粒通过可调节的抗生素释放消除了耐美西林的金黄色葡萄球菌
Haofei Li1, Longlong Yang1, Wenli Feng1
1State Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing 100029, PR China.
Colloids and surfaces. B, Biointerfaces
|April 9, 2024
概括
新型的多氨基酸纳米颗粒有效地提供抗生素来对抗抗甲素耐药黄金葡萄球菌 (MRSA). 可调节性质允许控制药物释放,用于增强细菌感染治疗.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 传染性疾病 传染性疾病
背景情况:
- 细菌感染,特别是抗甲素黄金葡萄球菌 (MRSA),构成了严重的公共卫生威胁.
- 新型治疗策略,包括先进的药物输送系统,对于打击抗生素耐药性至关重要.
研究的目的:
- 设计和合成基于聚氨基酸 (PAA) 的纳米粒子 (NP),用于针对性输送和可调节的抗生素释放.
- 调查水和结合相互作用在PAA自组装和药物加载/释放特征中的作用.
- 评估这些PAA-NP对MRSA感染的疗效.
主要方法:
- 通过光诱导的电子/能量转移-可逆添加碎片化链转移 (PET-RAFT) 聚合,利用N-烯基氨基酸 (氨酸,氨酸甲基,氨酸,氨酸) 合成四种两性PAA.
- 将PAA组装成纳米尺寸的输送系统,其特点是粒子大小,形态,药物加载效率和药物释放动力学.
- 对抗抗生素载荷PAA-NP对MRSA的抗菌性质的评估.
主要成果:
- 基于PAA的NP具有可调节的颗粒大小 (240.7302.7nm),药物加载效率 (9.57%19.76%),和Rifampicin (Rif) 释放率 (49.6%69.7%) 已成功合成.
- 疏水和结合相互作用显著影响了NP组件,形态,药物结合和释放动力学.
- 装有Rif的NP的抗菌疗效与可调节的Rifampicin释放直接相关,证明了受控的治疗潜力.
结论:
- 基于PAA的纳米颗粒为开发针对细菌感染的有效药物输送系统提供了一个多功能平台.
- 通过可控相互作用调整NP特性的能力为优化抗生素输送和打击MRSA提供了新的策略.
- 这项研究为设计用于传染病治疗的先进纳米药物开辟了新的途径.
相关概念视频
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...